Product Program year 2025 Source: CMS Open Payments

Tegsedi

Drug Neurology

NDC 72126-007-01

Open in the dashboard

General payments

$1,876,051

9,083 payments

Research payments

$1,830,192

157 payments

Through program year 2025, $1,876,051 in general payments and $1,830,192 in research payments were reported against Tegsedi (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 Research $68,854 1
2023 Research $238,088 81
2022 Research $337,305 38
2021 General $154,526 1,174
2021 Research $382,080 11
2020 General $450,292 2,986
2020 Research $648,860 16
2019 General $1,271,232 4,923
2019 Research $155,005 10

Breakdown

Who paid General payments · program years 2019–2021
  1. Akcea Therapeutics, Inc. $1,876,051 9,083 payments
Top recipients General payments · program year 2021
  1. Andrew Darlington Advanced Heart Failure and Transplant Cardiology · Fayetteville, GA $13,438 9% · 14 payments
  2. Reynolds Delgado Cardiovascular Disease · Houston, TX $9,213 6% · 11 payments
  3. Chafic Karam Neurology · Portland, OR $7,500 5% · 4 payments
  4. Sami Khella Neurology · Philadelphia, PA $6,839 4% · 5 payments
  5. Vanderbilt University Medical Center Teaching hospital · TN $6,300 4% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $42,087 30% · 37 practitioners
  2. Neurology Psychiatry & Neurology $26,054 19% · 160 practitioners
  3. Cardiovascular Disease Internal Medicine $18,491 13% · 159 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $7,691 6% · 24 practitioners
  5. Interventional Cardiology Internal Medicine $6,889 5% · 43 practitioners

The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Georgia $17,149 11% · 28 recipients
  2. Pennsylvania $16,010 10% · 50 recipients
  3. Tennessee $15,523 10% · 66 recipients
  4. California $15,214 10% · 85 recipients
  5. Florida $14,865 10% · 79 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

9,083 general · 157 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record